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Abstract. 
 
Increased microtubule density, for which mi-
crotubule stabilization is one potential mechanism, 
causes contractile dysfunction in cardiac hypertrophy. 
After microtubule assembly, 
 
a
 
-tubulin undergoes two, 
likely sequential, time-dependent posttranslational 
changes: reversible carboxy-terminal detyrosination 
 
(Tyr-tubulin 
 
« 
 
Glu-tubulin) and then irreversible de-
glutamination (Glu-tubulin 
 
® 
 
D
 
2-tubulin), such that 
Glu- and 
 
D
 
2-tubulin are markers for long-lived, stable 
microtubules. Therefore, we generated antibodies for 
Tyr-, Glu-, and 
 
D
 
2-tubulin and used them for staining 
of right and left ventricular cardiocytes from control 
cats and cats with right ventricular hypertrophy. Tyr-
tubulin microtubule staining was equal in right and left 
ventricular cardiocytes of control cats, but Glu-tubulin 
and 
 
D
 
2-tubulin staining were insignificant, i.e., the mi-
crotubules were labile. However, Glu- and 
 
D
 
2-tubulin 
were conspicuous in microtubules of right ventricular 
cardiocytes from pressure overloaded cats, i.e., the mi-
crotubules were stable. This finding was confirmed in 
terms of increased microtubule drug and cold stability 
in the hypertrophied cells. In further studies, we found 
an increase in a microtubule binding protein, microtu-
bule-associated protein 4, on both mRNA and protein 
levels in pressure-hypertrophied myocardium. Thus, 
microtubule stabilization, likely facilitated by binding 
of a microtubule-associated protein, may be a mecha-
nism for the increased microtubule density characteris-
tic of pressure overload cardiac hypertrophy.
 
W
 
e
 
 have shown on the levels of sarcomere and car-
diac muscle cell, or cardiocyte, that a persistent
increase in microtubule density accounts to a re-
markable degree for the contractile dysfunction seen in
pressure overload hypertrophy of the right ventricle (RV)
 
1
 
(Tsutsui et al., 1993, 1994). This discovery had its genesis
both in theoretical considerations (Hill and Kirschner,
1982) and in experimental observations (Joshi et al., 1985)
suggesting that an extending force, such as that exerted on
the cardiocyte by cardiac pressure loading, could rapidly
shift the dynamic equilibrium between free and polymer-
ized tubulin toward the polymerized form. However, our
previous work showed that while load modulation of the
set point of the tubulin–microtubule equilibrium may be
partially responsible for the induction and persistence of
increased microtubule density, other factors acting in a
less direct manner during and after hypertrophic growth
are also likely to be operative (Tagawa et al., 1996). In par-
ticular, the fact that microtubule density increases only af-
ter hypertrophic growth is initiated (Tagawa et al., 1996)
suggested microtubule stabilization as an attractive candi-
date explanation for this phenomenon.
To explore this hypothesis, we took advantage of the
fact that the 
 
a
 
-tubulin moiety of the 
 
ab
 
-tubulin het-
erodimer, once assembled into a microtubule, undergoes
two posttranslational modifications, such that the preva-
lence in microtubules of the first and then the second of
these modified forms of 
 
a
 
-tubulin serves as a clock indicat-
ing microtubule age. The first modification is a reversible
carboxy-terminal detyrosination by tubulin carboxypepti-
dase and retyrosination by tubulin tyrosine ligase (Tyr-
tubulin 
 
« 
 
Glu-tubulin) (Raybin and Flavin, 1975; Thomp-
son et al., 1979; Gundersen et al., 1984; Wehland and
Weber, 1987
 
a
 
,
 
b
 
). The second modification is irreversible
removal either of a second carboxy-terminal amino acid
from Glu-tubulin (Glu-tubulin 
 
® 
 
D
 
2-tubulin) or, less
likely, of both carboxy-terminal amino acids from Tyr-
tubulin (Tyr-tubulin 
 
® 
 
D
 
2-tubulin) (Paturle et al., 1989;
Paturle-Lafanechère et al., 1991, 1994). Thus, accumula-
tion of Glu-tubulin, and especially of 
 
D
 
2-tubulin, in micro-
tubules provides a marker for the age, and hence the sta-
bility, of these polymers (Barra et al., 1973; Borisy et al.,
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1. 
 
Abbreviations used in this paper
 
: EF-1
 
a
 
, translation elongation factor-
1
 
a
 
; LV, left ventricle; MAP 4, microtubule-associated protein 4; RV, right
ventricle.
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1975; Bulinski and Gundersen, 1991). To exploit these
markers of microtubule stability, we prepared antibodies
for Tyr-, Glu-, and 
 
D
 
2-tubulin and examined the preva-
lence of each in the microtubules of cardiocytes and in the
total protein of myocardium from normally loaded control
and pressure overload-hypertrophied ventricles.
If this hypothesis were found to be valid, three potential
explanations for increased microtubule stability, which
center on microtubule regulatory proteins, seemed most
plausible: first, an increased number of polymer nucleating
microtubule organizing centers, and thus of their constitu-
ent 
 
g
 
-tubulin (Joshi et al., 1992); second, a decrease in
translation elongation factor-1
 
a
 
 
 
(EF-1
 
a
 
), which has micro-
tubule severing activity (Shiina et al., 1994); and third, an
increase in the predominant cardiac microtubule-associ-
ated protein, MAP 4, which binds to and thereby may sta-
bilize microtubules (Bulinski and Borisy, 1979, 1980). We
addressed this question as well by generating antibodies to
these three microtubule regulatory proteins.
 
Materials and Methods
 
Experimental Models
 
Long-term RV pressure overload hypertrophy was induced by partially
occluding the pulmonary artery of cats with a 3.2-mm internal diameter
band, just as we have described before (Cooper et al., 1973
 
b
 
). These cats
were allowed to recover for 1 d to 6 mo. Short-term RV pressure overload
was induced as before (Rozich et al., 1995) by partial occlusion of the pul-
monary artery with a balloon-tipped cathether. In these cats, RV pressure
was doubled for 1 or 4 h. Long-term volume overload RV hypertrophy
was induced by resecting the interatrial septum during venous inflow oc-
clusion, again as described before (Cooper et al., 1973
 
a
 
). These cats were
allowed to recover for 2 or 4 wk. Controls consisted of sham-operated cats
submitted to thoracotomy and pericardiotomy without hemodynamic in-
tervention. In all cases, the left ventricle (LV) served as a same-animal
normally loaded control. All operative procedures were carried out under
full surgical anesthesia with meperidine (2.2 mg/kg i.m.), ketamine HCl
(50 mg/kg i.m.), and acepromazine maleate (0.25 mg/kg i.m.). All proce-
dures and the care of the cats were in accordance with institutional guide-
lines.
 
Hemodynamic Status
 
At terminal study, the control cats, the long-term pressure overload cats,
and the long-term volume overload cats were anesthetized as above. Right
heart and systemic arterial pressures were obtained as before (Tsutsui et
al., 1994). The arterio-venous difference in oxygen content was used as a
measure of the adequacy of systemic perfusion, and in the volume overload
cats the difference in percent oxygen saturation of hemoglobin between
the right atrium and the superior vena cava was used as the indication of a
left-to-right shunt at the atrial level. The short-term pressure overload cats
were anesthetized with meperidine (10 mg/kg i.m.), followed after 15 min
by methohexital sodium (20 mg/kg i.p.), and followed after a further 15 min
by 
 
a
 
-chloralose (60 mg/kg i.v.).
 
Cardiocyte Isolation
 
The enzymatic perfusion method that we use to obtain reproducible yields
of calcium-tolerant, quiescent cardiocytes from the RV and LV of cats has
been described in our previous work (Cooper et al., 1986; Mann et al.,
1989, 1991; Kent et al., 1989). After obtaining the RV and LV weights,
cardiocytes were isolated separately from each ventricle and maintained
for 1 h before further usage at 37
 
8
 
C in 1.8 mM Ca
 
2+
 
 mitogen-free M-199
medium at pH 7.4.
 
Posttranslationally Modified 
 
a
 
-Tubulin
 
Antibodies. 
 
Antibodies against native 
 
a
 
-tubulin and two posttranslation-
ally modified forms of 
 
a
 
-tubulin were prepared by the method of Gunder-
sen et al. (1984). The sequences of the peptide immunogens were: EEE-
GEEY (the carboxy-terminal amino acid sequence of native Tyr-tubulin),
GEEEGEE (the carboxy-terminal amino acid sequence of Glu-tubulin),
and EGEEEGE (the carboxy-terminal amino acid sequence of 
 
D
 
2-tubu-
lin). These peptides were KLH-conjugated by cross-linking with glutaral-
dehyde and injected into rabbits. Sera were monitored for antibody activ-
ity on slot blots using BSA-conjugated peptides. Antibody specificity was
validated by immunoblotts of purified Tyr-, Glu-, and 
 
D
 
2-tubulin isoforms,
a gift from L. Paturle-Lafanechère (Centre d’Etudes Nucleaires de Greno-
ble, France).
 
Myocardial Homogenates. 
 
After completion of the hemodynamic stud-
ies, the cats were heparinized (1,000 units i.v.) and placed on oxygen. A
midline thoracotomy was performed, the pericardium opened, and the
heart rapidly removed and weighed. The aorta was then cannulated, and
the coronary arteries were gently flushed with microtubule stabilization
buffer (Ostlund et al., 1979). Two 0.25-gm specimens were then excised
both from the RV and LV free walls for tubulin protein isolation. The re-
maining myocardium was immediately rinsed in ice-cold saline, after
which additional tissue from the RV and the LV free walls was excised
and flash-frozen in liquid nitrogen for RNA isolation. For immunoblot
analysis, 0.25-gm RV and LV specimens were homogenized in 5 ml of the
microtubule stabilization buffer and centrifuged at 100,000
 
 g
 
, 25
 
8
 
C for 15
min. The supernatants were saved as the free tubulin fractions, and the
pellets were resuspended at 0
 
8
 
C in 4 ml of microtubule depolymerization
buffer (Schliwa et al., 1981); after 1 h at 0
 
8
 
C they were centrifuged at
100,000 
 
g
 
, 4
 
8
 
C for 15 min, and the supernatants were saved as the poly-
merized tubulin fractions. The remaining 0.25-gm RV and LV specimens
were homogenized in 5 ml of microtubule depolymerization buffer, main-
tained for 1 h at 0
 
8
 
C, and centrifuged at 100,000 
 
g
 
, 4
 
8
 
C for 15 min. These
supernatants were saved as the total tubulin fractions. Protease and phos-
phatase inhibitors were used throughout.
 
Immunoblots. 
 
For the subsequent 12.5% SDS-PAGE, equal propor-
tions of free, polymerized, and total tubulin samples were loaded onto the
three lanes for each ventricle, and an equal amount of protein as deter-
mined by a bicinchoninic acid assay (BCA; Pierce Chem. Co., Rockford,
IL) was loaded for the RV and LV samples. The samples were transferred
to polyvinylidene difluoride membranes (500 mA, 120 min, 4
 
8
 
C) and
probed with a 1:5,000 dilution of a mAb to
 
 
 
a
 
-tubulin (DM1A; Amersham
Corp., Arlington Heights, IL) or 
 
b
 
-tubulin (DM1B; Amersham Corp.), or
with the Tyr-, Glu-, and 
 
D
 
2-tubulin antibodies which we had generated.
Bound antibody was visualized using a horseradish peroxidase-conjugated
secondary antibody (Vector Laboratories, Burlington, CA) and enhanced
chemiluminescence (ECL; Amersham Corp.). In all cases, a single 55-kD
band having the same mobility as concurrently run bovine brain 
 
b
 
-tubulin
was detected. Densitometric quantification of the immunoblots was car-
ried out as described before (Tsutsui et al., 1994).
This analysis of the free, polymerized, and total tubulin fractions was
validated in five cats by densitometry of blots probed with the 
 
b
 
-tubulin
antibody. The sum of the free and polymerized tubulin fractions was 89.0 
 
6
 
0.6% of the total tubulin fraction. When in these samples the residual pel-
let of the second centrifugation was boiled in SDS and immunoblotted,
the 
 
b
 
-tubulin was only 2.2 
 
6
 
 1.5% of that in the polymerized tubulin frac-
tion, and when the pellet containing the polymerized fraction was washed
with microtubule stabilization buffer, the free tubulin that had carried
over into the polymerized tubulin fraction was only 1.6 
 
6
 
 0.7% of that in
the polymerized tubulin fraction. Thus, the separation and measurement
of the three tubulin fractions was satisfactory.
 
Indirect Immunofluorescence Micrographs. 
 
For visualization of the ap-
pearance and density of the cardiocyte microtubule network, freshly iso-
lated RV and LV cardiocytes were sedimented onto laminin-coated cov-
erslips at 1
 
 g
 
 for 45 min, extracted for 1 min in 1% Triton X-100 (Sigma
Chemical Co., St. Louis, MO) in the microtubule stabilization buffer,
washed 3 times in the same buffer, and fixed for 30 min with 3.7% formal-
dehyde, all at 25
 
8
 
C. After blocking with 10% donkey serum in 0.1 M gly-
cine, the cells were incubated overnight at 4
 
8
 
C with a 1:50 dilution of the
same antibodies used for the immunoblots, followed by a fluorescein-con-
jugated secondary antibody (Jackson ImmunoResearch Laboratories,
West Grove, PA); 0.7-
 
m
 
m optical sections were then acquired by confocal
laser microscopy (LSM GB-200; Olympus Optical Co., Ltd., Tokyo, Japan).
 
Taxol Usage. 
 
To determine in normal cardiocytes whether the 
 
a
 
-tubulin
of stablized microtubules exhibits time-dependent posttranslational modi-
fications, 10
 
2
 
5
 
 M taxol, which inhibits microtubule depolymerization, was
added to a chamber containing freshly isolated cardiocytes, which were
sampled for immunofluorescence microscopy of native and posttransla-
tionally modified 
 
a
 
-tubulins after 0.0, 0.5, 1.0, and 2.0 h. 
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Microtubule Stability
 
Nocodazole. 
 
The prevalence of posttranslationally modified 
 
a
 
-tubulin in
cardiocyte microtubules was used as the primary measure of the age, and
thus the intrinsic stability, of these polymers. Resistance to nocodazole-
induced microtubule depolymerization was used as one of two additional
measures of microtubule stability. For this purpose, freshly isolated cardi-
ocytes were sedimented onto laminin-coated coverslips at 1
 
 g
 
 for 45 min,
washed twice with 0.3 
 
m
 
M nocodazole (Aldrich Chemical Co., Milwaukee,
WI) in PBS, exposed to 0.3 
 
m
 
M nocodazole in M-199 medium for 0.0, 0.5,
1.0, or 1.5 h, extracted for 1 min in 1% Triton X-100 (Sigma) in the micro-
tubule-stabilizing buffer, all at 25
 
8
 
C, and prepared as above for indirect
immunofluorescence confocal microscopy using the antibody to 
 
b
 
-tubulin
(DM1B; Amersham).
 
Low Temperature. 
 
The rate of microtubule depolymerization at 0
 
8
 
C was
used as the second additional measure of microtubule stability. For this
purpose, freshly isolated cardiocytes were sedimented onto laminin-
coated coverslips at 1 
 
g
 
 for 45 min and then immersed in 0
 
8
 
C M-199 me-
dium for 0.0 or 1.0 h, extracted for 1 min  in 1% Triton X-100 (Sigma) in
the microtubule-stabilizing buffer, and prepared as above for indirect im-
munofluorescence confocal microscopy using the antibody to 
 
b
 
-tubulin
(DM1B; Amersham).
 
Microtubule Regulatory Proteins
 
g
 
-Tubulin. 
 
An antibody against 
 
g
 
-tubulin was prepared as described
(Joshi et al., 1992). The sequence selected for the peptide immunogen was:
EEFATEGTDRKDVFFY (residues 38–53 of human 
 
g
 
-tubulin), since, ex-
cept for two amino acids, this sequence is conserved from yeast through
human. This peptide was KLH-conjugated by cross-linking with glutaral-
dehyde and injected into rabbits. The serum was monitored for antibody
activity on slot blots using BSA conjugated to the peptide. IgG was puri-
fied from whole antiserum by chromatography on a protein A/G column
(Pierce). Antibody specificity was validated by immunoblot analysis using
an extract from non-cardiocyte (interstitial and vascular) cells obtained
from feline hearts. For preparation of the noncardiocyte cell extract, cells
which adhered to a culture flask after enzymatic digestion of the feline
heart were cultured for 4 d in DMEM with 5% fetal calf serum. After re-
moval of the medium, the cell extract was prepared by solubilizing the
cells directly in a buffer consisting of 10 mM Tris, pH 6.8, and 1% SDS.
The protein concentration of each extract was determined by a bicincho-
ninic acid assay (BCA; Pierce).
For immunofluorescent localization of 
 
g
 
-tubulin in noncardiocytes,
cells cultured on coverslips were fixed by plunging them into –20
 
8
 
C meth-
anol for 5 min. The coverslips were air-dried, rehydrated in PBS, blocked
with 10% donkey serum in 0.1 M glycine, and incubated overnight at 4
 
8
 
C
with 1:50 dilutions of antibodies to 
 
b
 
-tubulin and 
 
g
 
-tubulin. Fluorescein-
conjugated anti-rabbit IgG and Cy3-labeled anti–mouse IgG (Jackson Im-
munoResearch Laboratories) were used as secondary antibodies. For im-
munofluorescent localization of 
 
g
 
-tubulin in feline cardiocytes, cells on
coverslips were fixed in methanol and stained as above.
 
Elongation Factor-1
 
a
 
. 
 
The prevalence of EF-1
 
a
 
 in the RVs and LVs
both of control cats and of cats with RV pressure overloading was esti-
mated from immunoblots. Total tubulin samples prepared as described
above were loaded on 12.5% SDS-PAGE gels, and EF-1
 
a
 
 was detected
with a polyclonal EF-1
 
a
 
 antibody (Shiina et al., 1994), a gift from E.
Nishida (Kyoto University, Japan).
 
Microtubule-associated Protein 4. 
 
Free, polymerized, and total tubulin
samples, prepared as described above, were used for immunoblot estima-
tion of MAP 4 protein levels in these fractions. The samples were loaded
on 7.5 or 12.5% SDS-PAGE gels; microtubule-associated proteins were
detected by antibodies to MAP 1, MAP 2, and tau (ICN Pharmaceuticals,
Inc., Costa Mesa, CA), as well as MAP 4; the latter was a gift from H.
Murofushi (Tokyo University, Japan). Neither MAP 1, MAP 2, nor tau
was detected in immunoblots of control or RV pressure overloaded myo-
cardium. Changes in MAP 4 were examined in the RVs and LVs both of
control cats and of cats with RV pressure overloading at 2 d and at 1, 2, 4,
and 8 wk after pulmonary artery banding.
Because the MAP 4 antibody was raised against bovine MAP 4 (Kotani
et al., 1988; Aizawa et al., 1991), we first ascertained its reactivity with
MAP 4 from other species, i.e., cat and human, using feline noncardiocyte
myocardial cells and human A431 cells grown in serum. These mitotically
competent cells would be expected to exhibit MAP 4 staining of the mi-
totic spindle when dividing. For immunofluorescent localization of cardio-
cyte MAP 4, freshly isolated feline cardiocytes sedimented onto laminin-
coated coverslips were fixed by plunging them into 
 
2
 
20
 
8
 
C methanol for 5
min. The coverslips were air-dried, rehydrated in PBS, and post-fixed with
3.7% formaldehyde in PBS for 30 min. They were blocked with 10% don-
key serum in 0.1 M glycine and incubated overnight at 4
 
8
 
C with 1:50 dilu-
tions of the monoclonal antibody to 
 
b
 
-tubulin and the MAP 4 antibody.
Fluorescein-conjugated anti-rabbit IgG and Cy3-labeled anti-mouse IgG
(Jackson ImmunoResearch Laboratories) were used as secondary anti-
bodies.
To estimate MAP 4 mRNA levels, poly(A)
 
1
 
 RNA was extracted from
frozen cardiac samples (FastTrack II; Invitrogen Corp., San Diego, CA).
To load equal amounts of poly(A)
 
1
 
 RNA on each lane of Northern blots,
the amount of 3
 
9
 
-UMP in each sample was measured as before (Tagawa et
al., 1996) via high pressure liquid chromatography, and 2 
 
m
 
g of poly(A)
 
1
 
RNA loaded on each lane was electrophoresed on denaturing 2% formal-
dehyde/1% agarose gels, followed by 2 h of pressure-driven blotting to a
nylon membrane (Hybond-N; Amersham Corp.). The RNA was then im-
mobilized on the nylon membrane by UV cross-linking (Stratalinker;
Stratagene, La  Jolla, CA). The nylon membrane was pre-hybridized for 4 h
at 42
 
8
 
C in a solution containing 50% (vol/vol) deionized formamide, 0.2%
(wt/vol) Ficoll, 0.02% (wt/vol) polyvinylpyrrolidone, 5
 
3 
 
SSC, 10 mM
MOPS, pH 7.0, 2 mM EDTA, 100 
 
m
 
g/ml denatured salmon sperm DNA,
and 0.2% (wt/vol) SDS. The membrane was hybridized for 16 h at 42
 
8
 
C in
a solution containing 
 
32
 
P-radiolabeled probe (5.0 – 10.0
 
 3 
 
10
 
6
 
 cpm/ml).
The Northern blots were washed three times in 2
 
3 
 
SSC, 0.1% SDS for 1.5
h at 40
 
8
 
C, followed by a wash in 0.2
 
3 
 
SSC, 0.1% SDS for 0.5 h at 42
 
8
 
C,
and then processed for autoradiography.
Three PCR-generated probes were prepared for MAP 4 Northern
blots. These were 313- and 288-bp probes corresponding to nucleotides
2807–3120 and 3275–3563, respectively, of the murine MAP 4 cDNA se-
quence (West et al., 1991) and a 223-bp probe corresponding to nucle-
otides 1925–2148 of the bovine MAP 4 cDNA sequence (Aizawa et al.,
1990). The murine MAP 4 cDNA was a gift from J. Olmsted (University
of Rochester, NY). Each blot was normalized as before with a GAPDH
probe PCR-generated from feline GAPDH cDNA (McDermott et al.,
1991).
 
Data Analysis
 
The mean value and the standard error of the mean are shown for each
group of data. For the data in the table, group means were first compared
by a one-way ANOVA, and if a difference was found, then each experi-
mental mean was compared with that of the control and any other groups
noted by the appropriate post-hoc test as specified.
 
Results
 
Characteristics of the Experimental Models
 
The goal of the present study was to examine both micro-
tubule stability and its regulation from the earliest stages
of RV pressure or volume overload hypertrophy induc-
tion, through completion of the hypertrophic growth
phase, and then into an extended period of stable hyper-
trophy. For pressure overload hypertrophy, the pulmo-
nary artery balloon catheter cats were used as the model
for early hypertrophy induction (1–4 h), and pulmonary
artery banding was used as the model both for the later
time points of active hypertrophic growth at 1 d, 2 d, 1 wk,
and 2 wk after banding and for the further time points of 1,
2, and 6 mo after banding when the mass of the hypertro-
phied RV is at a new steady state (Tagawa et al., 1996).
The short-term pulmonary artery balloon catheter cats
exhibited a doubling of RV systolic pressure without a sig-
nificant change in RV end-diastolic pressure. The major
features of the long-term surgical models used in this study
are summarized in Table I. As shown there, in the long-
term pressure overload pulmonary artery banding group,
RV systolic pressure was increased more than twofold,
while in the long-term volume overload atrial septal defect
group, there was a substantial shunt at the atrial level. For
both groups, the ratios of RV weight to body weight and 
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tibial length were increased significantly and comparably.
Body weight was similar in each group, and the ratio of LV
weight to body weight did not differ among the groups,
precluding any effect of postoperative changes in body
weight. In neither group was there evidence for right heart
failure in terms of either the presence of ascites and pleu-
ral effusion in any cat at the time of study or increases in
A-V O
 
2
 
 difference, RV end-diastolic pressure, or the ratio
of liver weight to body weight.
 
Microtubule Stability in Feline Cardiocytes
 
Specificity of Antibodies to Posttranslationally Modified
 
a
 
-Tubulin. Because the specificity of our Tyr-, Glu-, and
D2-tubulin antibodies was critically important to the valid-
ity of this study, a 100-ng aliquot of each purified a-tubulin
protein isoform was loaded on an SDS-PAGE gel, blotted,
and probed with all three antibodies. The Tyr-tubulin anti-
body showed no cross-reactivity with either Glu-tubulin or
D2-tubulin (Fig. 1 A). The Glu-tubulin antibody showed
only very minor cross-reactivity with Tyr-tubulin and none
with D2-tubulin (Fig. 1 B), and the D2-tubulin antibody
showed only minor cross-reactivity with Glu-tubulin (Fig.
1 C). Of note, cross-reactivity of any degree was not ob-
served when tubulin isoform quantities <50 ng were
loaded, an amount commensurate with the maximum
loading employed herein for the semiquantitative analysis
of posttranslationally modified a-tubulin isoforms.
Posttranslationally Modified a-Tubulin in Control Cardi-
ocytes. To determine whether the presence of posttran-
lationally modified a-tubulin isoforms is a valid index of
cardiocyte microtubule age, we exposed normal cardio-
cytes to taxol. This diterpene binds to microtubules and
prevents their depolymerization, such that the life-time of
the microtubules increases. Initially, as seen in the three
panels A in Fig. 2, the density of the microtubule network
stained with the Tyr-tubulin antibody was similar to that in
normal cells stained with the b-tubulin antibody (Tsutsui
et al., 1993); however, microtubule staining with the Glu-
tubulin and D2-tubulin antibodies was virtually absent. At
30 min of taxol exposure, as seen in the three panels B in
Fig. 2, there was a modest increase in the density of the mi-
crotubule array stained with the Tyr-tubulin antibody, and
microtubule decoration with the Glu-tubulin and D2-tubu-
lin antibodies, which as in differentiating myoblasts (Gun-
dersen et al., 1989) is punctate rather than uniform, was
just becoming apparent. At both 60 and 120 min of taxol
exposure, as seen in the three panels C and D, respec-
tively, in Fig. 2, the density of the microtubule array
stained with the Tyr-tubulin antibody increased further
coincident with continuing microtubule assembly; how-
ever, the density of the microtubule arrays stained with the
Glu-tubulin and D2-tubulin antibodies increased quite re-
markably, as the duration of taxol exposure increased, and
their constituent a-tubulin underwent progressive post-
Figure 1. Specificity of the antibodies to posttranslationally mod-
ified isoforms of a-tubulin. Immunoblot analysis. A 100-ng sam-
ple of a single a-tubulin isoform was loaded on each lane before
12.5% SDS-PAGE, where lane 1, Tyr-tubulin; lane 2, Glu-tubulin;
and lane 3, D2-tubulin. The blot in A was then probed with anti–
Tyr-tubulin antibody, the blot in B was probed with anti–Glu-tubu-
lin antibody, and the blot in C was probed with anti–D2-tubulin
antibody.
Table I. Characteristics of the Models
Control
(n 5 12)
ASD
(n 5 6)
PAB
(n 5 24)
RV Systolic Pressure
(mmHg)
26.1 6 1.1 29.4 6 1.3 55.9 6 1.5*‡
DO2% Saturation
(SVC vs. RA)
0.7 6 0.3 9.9 6 1.9* 0.5 6 0.3‡
RV weight/body weight
(g/kg)
0.58 6 0.04 0.86 6 0.06* 0.92 6 0.04*
RV weight/tibal length
(g/cm)
0.16 6 0.01 0.22 6 0.03* 0.21 6 0.01*
LV weight/body weight
(g/kg)
2.05 6 0.06 1.97 6 0.15 2.20 6 0.07
Body weight (kg) 3.7 6 0.2 3.6 6 0.5 3.4 6 0.1
Arteriovenous O2 difference
(ml/liter)
35.7 6 3.1 — 38.0 6 1.4
RV end-diastolic pressure
(mmHg)
2.3 6 0.6 1.6 6 0.6 2.5 6 0.5
Liver weight/body weight
(g/kg)
26.8 6 1.1 25.1 6 0.6 28.9 6 1.0
Values are mean 6SEM. ASD, atrial septal defect; PAB, pulmonary artery band;
SVC, superior vena cava; RA, right atrium. Statistical comparisons are by one-way
analysis of variance followed by Neuman-Keuls t test. For the ASD and PAB cats,
there was no within-group difference for any of these variables at the different experi-
mental time points; the within-group data are therefore grouped together.
*P , 0.01 for difference from control.
‡P , 0.01 for difference from ASD.Sato et al. Microtubules in Hypertrophied Cardiocytes 967
translational modification. Thus, successive posttransla-
tional modifications of microtubule-assembled a-tubulin
are a valid index of microtubule life-time in normal cardio-
cytes.
Microtubule Stability in Pressure Overload Hypertrophy.
The presence and quantity of posttranslationally modified
a-tubulin was then used to estimate microtubule stability
in cardiocytes from the hearts of cats with RV pressure
overload hypertrophy. In one such animal 2 wk after pul-
monary artery banding, Fig. 3 A shows that the density of
Tyr-tubulin-decorated microtubules is greater in the RV
than in the LV cardiocyte. Fig. 3, B and C shows that the
microtubules of the RV but not the LV cardiocytes are
decorated by the Glu-tubulin and D2-tubulin antibodies.
Of interest, double-staining of hypertrophied RV cardio-
cytes with both Glu-tubulin and D2-tubulin antibodies
showed coincident decoration of microtubules with both anti-
bodies (data not shown), such that a given microtubule
contained both posttranslationally modified forms of a-tubu-
lin. Findings similar to those in Fig. 3 obtained at 2 d, 1 wk,
1 mo, 2 mo, and 6 mo after pulmonary artery banding
(data not shown), such that cardiocyte microtubule stabili-
zation occurs early after RV pressure overloading and per-
sists indefinitely thereafter. Indeed, the posttranslationally
modified a-tubulin isoforms are appreciable in cardiocyte
microtubules even before increased density of the micro-
tubule network is apparent, since this latter phenomenon
is not clearly discernible until at least 1 wk after RV pres-
sure overloading (Tagawa et al., 1996).
A quantitative estimate of the extent of microtubule sta-
bilization in pressure-hypertrophied myocardium is pro-
vided in Fig. 4, which shows that, when assayed by the iso-
form nonselective b-tubulin antibody, there is a near
doubling of microtubule protein in the pressure-hypertro-
phied RV; the Tyr-tubulin data show that this does not in-
volve a disproportionate increase in newly formed micro-
tubules. The Glu-tubulin and Tyr-tubulin data, however,
show that there is a large and quite disproportionate in-
crease in long-lived, stable microtubules in which post-
translational modifications of a-tubulin have occurred in
the hypertrophied RVs. As was the case for the data in
Fig. 3, these findings at 2 wk after pulmonary artery band-
ing were confirmed at 2 d, 1 wk, 1 mo, 2 mo, and 6 mo after
pulmonary artery banding (data not shown). Thus, the in-
creased cardiocyte microtubule density seen in pressure
overload cardiac hypertrophy results not only from new
microtubule formation, but also from stabilization of these
microtubules once formed.
While the presence of posttranslationally modified a-tubu-
lin isoforms is an index of the age, and thus the intrinsic
stability, of the cellular microtubule array under native
conditions that obtained in vivo, the resistance of microtu-
bules to depolymerization either by microtubule poisons
or by low temperature is another commonly employed
measure of microtubule stability for isolated cells in vitro.
Fig. 5 shows that the resistance of the microtubule array to
depolymerization by either of these modalities is consider-
ably greater in hypertrophied RV than in control LV car-
diocytes at 2 wk after RV pressure overloading. Note that
while the initial density of the RV cardiocyte microtubule
array was greater than that of the LV cardiocyte (Fig. 5, A
vs. B and I vs. J), the relative difference in densities was far
more pronounced at the end point of each treatment (Fig.
5, G vs. H and K vs. L). Further, the residual microtubules
became much more fragmented in the LV as opposed to
the RV cardiocytes during exposure to either nocodazole
or low temperature. At 2 d after banding these changes
were not discernable, while at 1 wk after banding these
changes were present, albeit considerably less marked
than those shown in Fig. 5, probably reflecting a gradual
accumulation of stable microtubules (data not shown).
Thus, these data, which were replicated in a second exper-
imental animal at 2 wk after pulmonary artery banding,
confirm through an independent means those data ob-
tained from characterization of posttranslationally modi-
fied a-tubulin isoforms.
Microtubule Stability in Volume Overload Hypertrophy.
To determine whether increased microtubule stability is a
generalized property of hypertrophied cardiocytes or is in-
stead specific to the type of hemodynamic overload caus-
ative of the hypertrophy, we generated an equivalent de-
gree of feline RV hypertrophy in response to a volume
Figure 2. Taxol-induced microtubule stabilization in normal car-
diocytes. Immunofluorescence confocal micrographs of post-
translationally modified a-tubulin isoforms in the microtubules of
cardiocytes from a normal feline heart after exposure to 1025 M
taxol for 0 (A), 0.5 (B), 1.0 (C), and 2.0 h (D). As indicated, the
antibodies employed were, from above down, anti–Tyr-tubulin
antibody, anti–Glu-tubulin antibody, and anti–D2-tubulin anti-
body. Each micrograph is a single 0.7-mm confocal section taken
at the level of the nuclei. Double-staining of cells exposed to
taxol for 2 h both with the b-tubulin antibody and with either the
Tyr-tubulin, Glu-tubulin, or D2-tubulin antibodies showed that
the latter three antibodies decorated microtubules exclusively
(data not shown). Bar, 25 mm.The Journal of Cell Biology, Volume 139, 1997 968
overload as we had generated in response to a pressure
overload. In one such animal 2 wk after atrial septotomy,
Fig. 6 A shows first that the density of the microtubule net-
work decorated by the antibody specific for native Tyr-
tubulin is less in this volume-hypertrophied RV cardiocyte
than that seen in the pressure-hypertrophied RV cardio-
cyte (Fig. 3 A). Second, B and C of Fig. 6 show that post-
translationally modified a-tubulin isoforms are virtually
absent in these cardiocytes, just as they are in normally
loaded LV cardiocytes from the RV pressure-overloaded
hearts (Fig. 3). These findings, which were confirmed by
immunoblots, were replicated at 4 wk after atrial septot-
omy (data not shown). Thus, an equivalent degree and du-
ration of RV hypertrophy in response to a volume over-
load as that seen in response to a pressure overload results
neither in cardiocyte contractile dysfunction (Tsutsui et
al., 1993) nor in increased density or stability of the cardio-
cyte microtubule network.
Microtubule Regulatory Proteins
g-Tubulin. When the anti–g-tubulin antibody that we pre-
pared was used to probe extracts from non-cardiocytes
and cardiocytes from a normal feline heart, a clear band at
46 kD was seen for the noncardiocyte extract, but no band
was seen for the cardiocyte extract (data not shown), sug-
gesting that g-tubulin is not present in any appreciable
quantity in these cells. Immunofluorescence micrographs
confirmed these observations: cardiac fibroblasts showed
clear g-tubulin staining in well-defined microtubule orga-
nizing centers; however, cardiocytes showed no g-tubulin
staining, and the same finding obtained in pressure-hyper-
Figure 3. Microtubule stabil-
ity in pressure overload-
hypertrophied myocardium:
Immunofluorescence confo-
cal micrographs of posttrans-
lationally modified a-tubulin
isoforms in RV and LV car-
diocyte microtubules from a
feline heart 2 wk after RV
pressure overloading. The
anti–Tyr-tubulin antibody
was used in A, the anti–Glu-
tubulin antibody was used in
B, and the anti–D2-tubulin an-
tibody was used in C. Each
micrograph is a single 0.7-mm
confocal section taken at the
level of the nuclei. Bar, 25 mm.
Figure 4. Densitometric analysis of microtubule stability in pres-
sure overload-hypertrophied myocardium. b-tubulin and post-
translationally modified a-tubulin isoforms in microtubules of
RVs and LVs from the same feline hearts. Control cats were
compared with cats RV pressure overloaded 2 wk earlier via pul-
monary artery banding. Four blots were prepared for each heart;
the microtubule fractions from the RV and LV (20 mg protein/
lane) were loaded on two lanes, and four concentrations of the
appropriate protein standard (7.5–60.0 ng/lane) were loaded on
the remaining lanes before 12.5% SDS-PAGE; the blot was then
probed with the corresponding antibody. For the protein stan-
dards, the linear relationship between optical density and protein
loaded had a correlation coefficient >0.98 in each instance. Of
the total a-tubulin, Tyr-tubulin comprised 92.6 6 2.1%, Glu-tubu-
lin was 4.6 6 1.4%, and D2-tubulin was 2.8 6 0.7%. Statistical
comparisons were by one-way ANOVA followed by Scheffé’s S
procedure, where n 5 number of cats in each group.*P , 0.01 for
difference within a category from the control group value by
Scheffé’s S procedure. ‡P , 0.01 for difference from the b-tubu-
lin and Tyr-tubulin values within the hypertrophy group by
Scheffé’s S procedure.Sato et al. Microtubules in Hypertrophied Cardiocytes 969
trophied cardiocytes (data not shown). Therefore, g-tubu-
lin–containing microtubule organizing centers, at least
within the sensitivity of this measurement, are absent from
adult cardiocytes, such that an increased number of these
microtubule nucleating sites would appear to be excluded
as a cause for the increased cardiocyte microtubule net-
work density characteristic of pressure overload cardiac
hypertrophy.
Elongation Factor-1a. Immunoblots of control cat myo-
cardium and of RV myocardium at 0, 1, 2, 14, and 30 d af-
ter RV pressure overloading showed both that EF-1a pro-
tein concentrations are the same in all animals in the RV
and in the LV and that there is no change in EF-1a protein
concentration in the hypertrophied RVs (data not shown).
Thus, reduced microtubule degradation based on reduced
EF-1a content would also appear to be excluded as a
cause for the increased cardiocyte microtubule density
characteristic of pressure overload cardiac hypertrophy.
Microtubule-associated Protein 4. Although as noted the
MAP 4 antibody which we used was raised against bovine
MAP 4 as the immunogen, immunofluorescence staining
of human A431 cells and feline cardiac fibroblasts showed
strong reactivity with the spindle fibers of dividing cells
(data not shown), such that this antibody has significant
species cross-reactivity. The immunoblots in A (control
heart) and B (2 wk pulmonary artery banded heart) of Fig.
7, for which equal protein loading was employed, show
first that most of the MAP 4 is, as expected, located in the
microtubule fraction (the total tubulin fraction in lanes 5
and 6 includes both free and polymerized tubulin) and sec-
ond that there is a marked increase in MAP 4 protein in
the pressure-hypertrophied RV myocardium; no bands
other than those shown in this figure were apparent in
these immunoblots. The micrographs in C and D of Fig. 7
are confirmatory: the minimal MAP 4 staining of the con-
trol cardiocyte is not well localized to the microtubules,
while the hypertrophied cardiocyte shows strong MAP 4
staining, with coincident decoration of the dense microtu-
bule network both with the anti–b-tubulin antibody and
with the anti–MAP 4 antibody. This latter finding was con-
firmed in further RV and LV cardiocytes at 2 d, 1 wk, 1
mo, and 2 mo after RV pressure overloading. Thus, in the
evanescent microtubules of normal cardiocytes, very little
of the relatively small MAP 4 pool is decorating the micro-
tubules, while the long-lived microtubules of the hypertro-
phied cardiocytes are binding a significant fraction of a
markedly increased pool of MAP 4 protein.
Figure 5. Microtubule stability in pressure overload-hypertro-
phied myocardium: Immunofluorescence confocal micrographs,
using the DM1B anti–b-tubulin antibody, of RV and LV cardio-
cyte microtubules during exposure to nocodazole (A–H) or low
temperature (I–L). Cardiocytes from a feline heart 2 wk after RV
pressure overloading were exposed to 0.3 mM nocodazole for 0
min (A and B), 30 min (C and D), 60 min (E and F), or 90 min (G
and H) or they were exposed to a temperature of 08C for 0 (I and
J) or 60 min (K and L) before fixation. The cardiocytes on the left
(A, C, E, G, I, and K) are from the RV, and the cardiocytes on
the right (B, D, F, H, J, and L) are from the LV. Of interest, after
90 min of nocodazole exposure the majority of the residual mi-
crotubules of RV but not LV cardiocytes was found by double-
staining to be decorated by both the b-tubulin and either the
Glu-tubulin or D2-tubulin antibodies (data not shown). Each
micrograph is a single 0.7-mm confocal section taken at the level
of the nuclei. Bar, 25 mm.
Figure 6. Microtubule stability in volume overload-hypertrophied
RV myocardium. Immunofluorescence confocal micrographs of
posttranslationally modified a-tubulin isoforms in microtubules
of RV cardiocytes from a feline heart 2 wk after RV volume
overloading. Anti–Tyr-tubulin antibody was used in A, anti–Glu-
tubulin antibody was used in B, and anti–D2-tubulin antibody was
used in C. Each micrograph is a single 0.7-mm confocal section
taken at the level of the nuclei. Bar, 25 mm.The Journal of Cell Biology, Volume 139, 1997 970
To gain insight into the potential role of MAP 4 in mi-
crotubule stabilization, the relative upregulation on the
protein level of b-tubulin and MAP 4 in hypertrophied
RV myocardium was examined. Fig. 8 shows that while
both b-tubulin and MAP 4 are increased in hypertrophied
RV as opposed to normal LV myocardium, the increase in
MAP 4 is greater than that in b-tubulin. Indeed, densito-
metric analysis of immunoblots from 4 cats with RV pres-
sure overload hypertrophy showed that the RV/LV ratio
of MAP 4 was threefold greater than the RV/LV ratio of
b-tubulin.
Fig. 9 shows the time course of MAP 4 upregulation in
pressure overload-hypertrophied myocardium on the mRNA
and protein levels. A and B show that RV MAP 4 mRNA
increases substantially by 4 h after pressure loading, whereas
b-tubulin and a-tubulin mRNA upregulation is not seen
until 1 d after pressure loading (Tagawa et al., 1996), and
MAP 4 mRNA remains elevated at least until the hyper-
trophic growth process is complete 2 wk later. Fig. 9, C and
D show that the resultant increase in RV MAP 4 protein is
apparent as early as 2 d after pressure loading and persists
indefinitely thereafter.
Thus, the data in Figs. 8 and 9 show that MAP 4 is up-
regulated both more quickly and more extensively than tu-
bulin after cardiac pressure loading. While this certainly
does not establish a cause-and-effect relationship, it does
constitute a basis for positing a role for MAP 4 in microtu-
bule stabilization and/or tubulin upregulation.
Discussion
The cardiocyte contractile dysfunction characteristic of
pressure overload cardiac hypertrophy is accounted for to
a remarkable degree by increased density of the cellular
microtubule network (Tsutsui et al., 1993, 1994), which im-
poses a primarily viscous load on active myofilaments; that
is, structural damping via intracellular frictional dissipa-
tion that impedes sarcomere shortening (Tagawa et al.,
1997). This is accompanied by persistent increases in
a- and b-tubulin on both the mRNA and protein levels
(Tagawa et al., 1996). Thus, increased synthesis of ab-tubu-
lin heterodimers, effecting in turn microtubule formation,
is one apparent cause for this greater microtubule density.
Given, however, that the ab-tubulin heterodimer–micro-
tubule system is in dynamic equilibrium, enhanced micro-
tubule stability is a second, and potentially synergistic,
candidate mechanism for augmented microtubule density.
This study was designed to evaluate this second potential
mechanism.
The restriction of the two sequential posttranslational
Figure 7. MAP 4 protein in
pressure overload-hypertro-
phied RV and control LV my-
ocardium. Immunoblot and
immunofluorescence confocal
micrographic analysis of MAP
4. The immunoblot in A was
prepared from a normal feline
heart, and the immunoblot in
B was prepared from a feline
heart 2 wk after RV pressure
overloading. For both panels,
lanes 1 and 2 were prepared as
the free tubulin fraction, lanes
3 and 4 were prepared as the
polymerized tubulin fraction,
and lanes 5 and 6 were pre-
pared as the total tubulin frac-
tion. Lanes 1, 3, and 5 of the
immunoblots are from the RV,
and lanes 2, 4, and 6 of the im-
munoblots are from the LV.
Each blot was probed with
anti–MAP 4 antibody. C is a
micrograph of a cardiocyte
from a normal feline heart,
and  D is a micrograph of a RV
cardiocyte from a feline heart
2 wk after RV pressure over-
loading. These cardiocytes were
double-stained for b-tubulin
(red) and MAP 4 (green), where
the b-tubulin and MAP 4 pri-
mary antibodies were followed
by species-specific fluorochrome-
conjugated secondary antibod-
ies. Each micrograph is a single
0.7-mm confocal section taken
at the level of the nuclei.Sato et al. Microtubules in Hypertrophied Cardiocytes 971
modifications of a-tubulin solely to microtubule-assem-
bled a-tubulin (Bulinski and Gundersen, 1991; Paturle-
Lafanechère et al., 1994) provided an attractively simple
and specific strategy for this evaluation. This strategy for
estimating microtubule age, which has been applied in
other contexts (Schulze and Kirschner, 1987; Webster et
al., 1990), has the very conspicuous advantage of not mod-
ifying the tubulin–microtubule equilibrium, as must inevi-
tably occur with the usage of tubulin binding agents or the
microinjection of fluorochrome-labeled tubulin. Further,
in contrast to the situation in nervous tissue and testis, es-
sentially all muscle a-tubulin participates in this cycle of
posttranslational modifications (Alonso et al., 1993). Our
success in this effort has allowed us to conclude that the
microtubules of pressure-hypertrophied cardiocytes do, in
fact, demonstrate markedly enhanced stability, wherein
microtubule stabilization begins very shortly after cardiac
pressure overloading and persists indefinitely thereafter.
We then focused on the basis for this microtubule stabi-
lization. Here, initial insight was provided by the two findings
that there is not only a conspicuous increase in microtu-
bules in hypertrophied myocardium, but also a dispropor-
tionate increase in stable microtubules (Fig. 4). Further,
neither increased microtubule nucleation nor decreased
microtubule breakdown appear to be operative mecha-
nisms for the microtubule network densification charac-
teristic of pressure overload cardiac hypertrophy. That is,
while microtubule polymerizing and/or depolymerizing
mechanisms other than those which we examined could
well be effectual, neither is there an increase in microtu-
bule nucleating g-tubulin nor is there a decrease in micro-
tubule depolymerizing EF-1a. With respect to g-tubulin, as
is the case in neuronal axons (Baas and Joshi, 1992), we
found no g-tubulin–containing microtubule organizing
center in the terminally differentiated cardiocyte; this find-
ing is consistent with the known absence of centrosomal
microtubule organizing centers from interphase striated
muscle cells (Kronebusch and Singer, 1987). Thus, increased
microtubule density in hypertrophied cardiocytes is not
based on an increased number of the g-tubulin–containing
microtubule organizing centers ordinarily responsible for
microtubule nucleation (Archer and Solomon, 1994). With
respect to EF-1a, the quantity of this protein does not
change in the pressure-overloaded RV at any point in the
hypertrophy process. Therefore, it is unlikely that reduced
EF-1a–based microtubule severing (Shiina et al., 1994,
1995) is causative of increased microtubule density in hy-
pertrophied cardiocytes. Indeed, since the microtubule
severing activities of EF-1a, as well as those of katanin
(McNally and Vale, 1993) and centrin (Sanders and Salis-
bury, 1994), tend to be spatially associated with the cen-
trosome and temporally associated with the G2–M phase
transition of the cell cycle, and since the cardiocyte both
apparently lacks a classical centrosome and is terminally
differentiated, a reduction in endogenous cellular microtu-
bule severing activity would not be expected during car-
diac hypertrophy.
Considering, then, the extra-microtubule factor(s) which
might stabilize cardiocyte microtubules, MAP 4 was both
an obvious candidate in that it is the predominant nonmo-
tor MAP of cardiac muscle (Olmsted, 1986) and a logical
Figure 8. Upregulation of b-tubulin versus MAP 4 protein in
pressure overload-hypertrophied myocardium. Immunoblot analy-
sis. The samples for each lane were prepared as the total tubulin
fraction, and equal protein loading was employed for the RV and
LV samples. For b-tubulin, the DM1B antibody used here recog-
nizes all b-tubulin isoforms. While both b-tubulin and MAP 4
were greater in the hypertrophied RV than in the same-animal
normally loaded LV, densitometric analysis of immunoblots from
4 such cats RV pressure overloaded 2 wk earlier via pulmonary
artery banding showed that the RV/LV ratio of MAP 4 was 3.0 6
0.5-fold greater than the RV/LV ratio of b-tubulin.
Figure 9. Time course of MAP 4 mRNA and protein upregula-
tion in control LV and pressure overload-hypertrophied RV
myocardium. Northern blot and immunoblot analysis. (A and B)
At the indicated times after RV pressure overloading, poly(A)1
RNA was prepared from the RV and LV of each heart, and 1 mg
was loaded on each lane. The blot in A was probed for MAP 4,
and the blot in B, which was used to verify equal RV versus LV
loading at each time point, was probed for constitutively ex-
pressed glyceraldehyde-3-phosphate dehydrogenase. (C and D)
At the indicated times after RV pressure overloading, the total
tubulin protein fraction was prepared from the RV and LV of
each heart, and 40 mg was loaded on each lane before probing
with anti–MAP 4 antibody. Note that the time points chosen for
the mRNA and protein blots do not coincide.The Journal of Cell Biology, Volume 139, 1997 972
candidate in that its functional role has been thought to be
the stabilization of microtubules during the interphase
portion of the cell cycle (Bulinski and Borisy, 1979, 1980).
Fig. 7 shows that indeed there is a clear increase in MAP 4
protein in the pressure-hypertrophied RV, that this pro-
tein is preferentially localized to the microtubule fraction
by immunoblotting, and that MAP 4 colocalizes with mi-
crotubules micrographically. Fig. 8 shows that this increase
in MAP 4 is considerably greater than the increase in tu-
bulin in hypertrophied myocardium. Fig. 9 shows further
that MAP 4 mRNA increases as early as 4 h after RV pres-
sure overloading, with this increase persisting throughout
the hypertrophy process, while increased MAP 4 protein is
seen as early as 2 d after RV pressure overloading, with
this increase, as is the case for microtubule densification
and microtubule-related cardiocyte contractile dysfunction
(Tsutsui et al., 1994), persisting indefinitely thereafter. Of
note, MAP 4 upregulation occurs earlier after myocardial
pressure loading than does tubulin upregulation (Tagawa
et al., 1996). In considering the sequence of these changes,
however, one must recognize both that techniques having
greatly different sensitivities are being used and that the
kinetics of the first appearance of a molecule as reported
by a relatively sensitive measure such as Northern or
Western blotting may be very different from the kinetics
of the accumulation of a macromolecular array as re-
ported by a relatively insensitive measure such as micro-
scopically assessed microtubule density. In this context, it
is by no means surprising that MAP 4 is upregulated on
the message level at 4 h and then on the protein level at
1–2 d, with the presumably related change in microtubule
density only becoming apparent several days later. Finally,
immunoblots of tissue homogenates from pressure over-
load-hypertrophied RVs and normally loaded control LVs,
using anti-phosphothreonine and anti-phosphoserine anti-
bodies, failed to detect a z200-kD band (data not shown),
such that the MAP 4 of neither hypertrophied nor normal
myocardium is significantly phosphorylated on those resi-
dues within the basic MAP 4 microtubule binding domain
which, when phosphorylated, inhibits MAP 4–microtubule
binding (Aizawa et al., 1991). Thus, while a direct cause
and effect relationship clearly has not been established,
MAP 4 stabilization of the cardiocyte microtubule array
would appear to be a logical candidate etiology for the in-
creased microtubule density, and thereby the functional
consequence of impaired cardiocyte contractile function,
characteristic of pressure overload cardiac hypertrophy.
In counterpoise, however, to this invitingly straightfor-
ward linkage of MAP 4 to microtubule stability, are recent
data from several non-muscle cultured cell systems. Over-
expression of MAP 4 was found to affect neither the quan-
tity nor the assembly of tubulin, nor did it affect microtu-
bule morphology or stability (Barlow et al., 1994). Antibody
depletion of MAP 4 was similarly without apparent effect
(Wang et al., 1996). While such studies have uncertain rel-
evance to long-term cytoskeletal regulation in the intact
organism, they do imply quite clearly that there must at
least be redundancy for any microtubule regulatory roles
of this structural MAP in the cell types employed. How-
ever, the applicability to cardiac and skeletal muscle of this
apparently restricted role of MAP 4 in regulating microtu-
bule properties would appear to be quite doubtful, since
the striated muscle-specific variant of MAP 4 has an un-
equivocally obligatory role both in the differentiation and
morphogenesis of muscle cells and in the organization of
their microtubule array (Mangan and Olmsted, 1996).
In the particular context of the present study it would
seem especially unlikely that the upregulation of two func-
tionally related proteins, in the setting of cardiocyte hyper-
trophic growth wherein changes in the cellular molecular
phenotype are minimal, is fortuitous. Thus apart from the
direct relationship of MAP 4 to microtubule stability, what
linkage might exist? And specifically, why is MAP 4 and
tubulin upregulation coordinate, and how does their joint
upregulation relate to greater microtubule density? Here,
it is of interest that in the course of neuronal development
there is coordinate regulation of the expression of the
several neuronal MAP isoforms as well as of the multiple
a- and b-tubulin isoforms (Oblinger and Kost, 1994).
Thus, one can speculate that with hypertrophic cardiac
growth re-initiation in specific hemodynamic settings,
there may be coordinate upregulation of both MAP and
tubulin genes as well as coordinate growth-related changes
in isoform expression. In this context, it is notable that
while for the most part the a-tubulin and b-tubulin iso-
forms are functionally equivalent in terms of coassembly
into microtubules (Lewis et al., 1987), it is the carboxy-ter-
minal isoform-variable domain of these tubulins that ap-
pears to be most important to MAP binding kinetics and,
thereby, to microtubule stability (Cleveland, 1987; Mac-
cioni et al., 1988). As an example, again in neuronal sys-
tems, a change in the proportion of the three major b-tubu-
lin isoforms has a substantial effect on microtubule stability
in these cells (Ludueña, 1993; Panda et al., 1994), such that
variation in the ratio of expressed b-tubulin isoforms may
represent a means by which the stability of the cellular mi-
crotubule array is regulated in response to differing physio-
logical input.
The purpose of this study was to determine whether, in
addition to greater tubulin and thus microtubule synthesis,
enhanced microtubule stability has a role in the microtu-
bule densification characteristic of the pressure overload-
hypertrophied cardiocyte. The two major findings of this
study are that the microtubules of these cells exhibit
greatly enhanced stability and that this is associated with
the upregulation of MAP 4, the major structural MAP of
the heart. While it is possible that the earlier and greater
upregulation of MAP 4 as opposed to tubulin is driving the
increase in microtubule quantity and stability, a direct role
for MAP 4 in these functions has not been established
here and is in some question, albeit in the restricted con-
text of acute experiments in isolated non-muscle cells. In
view both of the interrelated developmental regulation of
tubulin and MAP 4 genes, and of the potential for differ-
ing b-tubulin isoforms to alter microtubule stability either
directly via differing intrinsic properties or indirectly via
differing MAP 4 affinities, it will be of considerable interest
to determine whether there are isoform-specific changes in
cytoskeletal protein gene expression in the pressure-hyper-
trophied cardiocyte.
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